ATHIRA PHARMA INC. - COMMON STOCK

Athira Pharma to Present ATH-1017 Phase 1 Translational Data at the Alzheimer’s Association International Conference 2021 (AAIC)

19 Jul 2021 07:00:01 By Nasdaq GlobeNewswire

Athira Pharma Announces Initiation of Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of ATH-1017 for Alzheimer’s Disease

06 Jul 2021 07:00:00 By Nasdaq GlobeNewswire

Athira Pharma Chief Operating Officer, Mark Litton, Assumes Day-to-Day Leadership Responsibilities of Company

17 Jun 2021 17:00:00 By Nasdaq GlobeNewswire

Athira Pharma Appoints Rachel Lenington as Chief Technology Officer, Head of Product Development Strategy

14 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

Athira Pharma to Present at Upcoming Investor Conferences

09 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

Athira Pharma Appoints Mark Worthington as General Counsel

01 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

Athira Pharma to Present at Upcoming Investor Conferences

26 May 2021 07:00:01 By Nasdaq GlobeNewswire

Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights

13 May 2021 16:02:00 By Nasdaq GlobeNewswire

Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum

21 Apr 2021 07:00:00 By Nasdaq GlobeNewswire

Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair Pathway

08 Apr 2021 07:00:00 By Nasdaq GlobeNewswire

Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights

25 Mar 2021 16:02:00 By Nasdaq GlobeNewswire

Athira Pharma to Present at Stifel’s 3rd Annual CNS Conference

24 Mar 2021 07:00:00 By Nasdaq GlobeNewswire

Athira Pharma to Participate in Panel and Corporate Presentations at Life Science Innovation Northwest Conference

23 Mar 2021 07:00:01 By Nasdaq GlobeNewswire

Athira Pharma Announces Appointment of Barbara Kosacz to its Board of Directors

08 Mar 2021 07:00:00 By Nasdaq GlobeNewswire

Athira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences Conference

02 Mar 2021 07:00:02 By Nasdaq GlobeNewswire

Athira Pharma Announces Exercise of Underwriters’ Option to Purchase Additional Shares

10 Feb 2021 16:05:00 By Nasdaq GlobeNewswire

Athira Pharma Announces Pricing of Public Offering of Common Stock

20 Jan 2021 19:35:44 By Nasdaq GlobeNewswire

Athira Pharma Announces Proposed Public Offering of Common Stock

19 Jan 2021 07:59:37 By Nasdaq GlobeNewswire

Athira Pharma to Present at the 39th Annual J.P. Morgan Healthcare Conference

07 Jan 2021 07:30:00 By Nasdaq GlobeNewswire